These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Arterial hypertension secondary to the application of 9-alpha-fluoroprednisolone ointments]. Arnal JM; Moneo MI; Loris C An Esp Pediatr; 1987 Jan; 26(1):65-6. PubMed ID: 3826948 [No Abstract] [Full Text] [Related]
6. Pseudohyperaldosteronism due to application of an antihemorrhoid cream. Marin F; González Quintela A; Moya M; Suárez E; de Zárraga M Nephron; 1989; 52(3):281-2. PubMed ID: 2739869 [TBL] [Abstract][Full Text] [Related]
7. Hypokalemic myopathy in pseudohyperaldosteronism induced by fluoroprednisolone-containing nasal spray. Vita G; Bartolone S; Santoro M; Toscano A; Carrozza G; Girlanda P; Frisina N Clin Neuropathol; 1987; 6(2):80-5. PubMed ID: 3594977 [TBL] [Abstract][Full Text] [Related]
8. [A hypokalemic normotensive variant of the syndrome caused by nasal spray containing 9-alpha-fluoroprednisolone]. Mammarella A; Barlattani M; Bucci O; Fattori F; Filippello CP; Cugini P; Piernatale L; Letizia C; Murano G Clin Ter; 1985 Jan; 112(1):9-19. PubMed ID: 4017454 [No Abstract] [Full Text] [Related]
9. Hypokalemic rhabdomyolysis secondary to pseudohyperaldosteronism due to the use of a lotion containing 9-alpha-fluoroprednisolone. Mijares RP Nephron; 1986; 43(3):232-3. PubMed ID: 3724933 [No Abstract] [Full Text] [Related]
10. [Hypokalemic myopathy caused by fluoroprednisolone in a nasal spray. Observations 2 cases]. Cantello R; Bergamini L; Delsedime M; Durelli L; Troni W; Gilli M; Cocito D Minerva Med; 1983 Jun; 74(25):1463-7. PubMed ID: 6856155 [TBL] [Abstract][Full Text] [Related]
11. [Exogenous hypermineralocorticism caused by a nasal spray containing 9-alpha fluoroprednisolone]. Virgolini L; Geatti O; Giunta G Minerva Cardioangiol; 1984; 32(7-8):473-5. PubMed ID: 6208510 [No Abstract] [Full Text] [Related]
12. [Severe hypopotassemia and rhabdomyolysis in a normotensive subject after use of a nasal spray containing 9-alpha-fluoroprednisolone]. Wu SC; Secchi MB; Mancarella S; Oltrona L; Bettazzi L; Sale M; Ambrosi B Recenti Prog Med; 1989 Apr; 80(4):195-6. PubMed ID: 2762657 [TBL] [Abstract][Full Text] [Related]
13. Rhabdomyolysis, oedema and arterial hypertension: different syndromes related to topical use of 9-alpha-fluoroprednisolone. Lauzurica R; Bonal J; Bonet J; Romero R; Teixido J; Serra A; Caralps A J Hum Hypertens; 1988 Oct; 2(3):183-6. PubMed ID: 3236321 [TBL] [Abstract][Full Text] [Related]
14. [Hypermineralocorticism secondary to the topical use of corticoids]. Rama H; Carreras L; Martínez-Amenos A; Sarrias X Rev Clin Esp; 1984 Aug 15-31; 174(3-4):111-4. PubMed ID: 6515071 [No Abstract] [Full Text] [Related]
15. Pseudoaldosteronism due to 9-alpha-fluoroprednisolone creams. Morán JM; De Sancho JL; Abaigar P; Amenabar J; Muñiz R; Lampreabe I Clin Nephrol; 1984 Dec; 22(6):323-4. PubMed ID: 6525775 [No Abstract] [Full Text] [Related]
16. Hypermineralocorticoidism due to topical application of 9 alpha-fluoroprednisolone. Sanchez M; Perez-Garcia R; Lazaro P; López-Gomez JM; Valderrábano F Clin Nephrol; 1984 Nov; 22(5):267-8. PubMed ID: 6518677 [No Abstract] [Full Text] [Related]
17. [Hypokalemic myopathy, high levels of muscle enzymes and myocardial ischemia secondary to the topical administration of 9-alpha-fluoro-prednisolone]. Cosentino F; Mantelli I; Cosentino F Clin Ter; 1986 Mar; 116(6):509-11. PubMed ID: 3720236 [No Abstract] [Full Text] [Related]
18. Mineralocorticoid hypertension due to a nasal spray containing 9 alpha-fluoroprednisolone. Mantero F; Armanini D; Opocher G; Fallo F; Sampieri L; Cuspidi B; Ambrosi C; Faglia G Am J Med; 1981 Sep; 71(3):352-7. PubMed ID: 6169277 [TBL] [Abstract][Full Text] [Related]
19. [Severe hypokalemic episode induced by abuse of fluoro-prednisolone acetate administered nasally and the simultaneous oral consumption of indapamide]. Di Giacomo V; Tedeschi A Clin Ter; 1985 Jan; 112(2):163-7. PubMed ID: 4017458 [No Abstract] [Full Text] [Related]